| 11702392 |
Pyrimidinone derivatives as SHP2 antagonists |
Catherine Jorand-Lebrun, Roch Boivin, Theresa L. Johnson, Yanping Wang, Yufang Xiao +3 more |
2023-07-18 |
$421,006,000 |
| 11512069 |
TLR7/8 antagonists and uses thereof |
Brian A. Sherer, Esther Cleary, Nadia Brugger |
2022-11-29 |
$222,450,000 |
| 11001561 |
Pyrimidinone derivatives as SHP2 antagonists |
Catherine Jorand-Lebrun, Roch Boivin, Theresa L. Johnson, Yanping Wang, Yufang Xiao +3 more |
2021-05-11 |
$173,441,000 |
| 10947214 |
TLR7/8 antagonists and uses thereof |
Brian A. Sherer, Esther Cleary, Nadia Brugger |
2021-03-16 |
$129,391,000 |
| 10836750 |
TLR7/8 antagonists and uses thereof |
Brian A. Sherer, Nadia Brugger, Ruoxi Lan |
2020-11-17 |
$293,951,000 |
| 10793553 |
TLR7/8 antagonists and uses thereof |
Brian A. Sherer, Nadia Brugger, Ruoxi Lan |
2020-10-06 |
$187,967,000 |
| 10517872 |
Pyridazinone macrocycles as IRAK inhibitors and uses thereof |
Ruoxi Lan, Catherine Jorand-Lebrun, Henry Yu, Andreas Goutopoulos |
2019-12-31 |
$136,403,000 |
| 10287300 |
Heterocyclic derivatives as modulators of kinase activity |
Ruoxi Lan, Bayard R. Huck, Yufang Xiao |
2019-05-14 |
$81,943,000 |
| 10233160 |
Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors |
Bayard R. Huck, Ruoxi Lan, Justin Potnick, Lizbeth Celeste Deselm, Mark Cronin +4 more |
2019-03-19 |
$169,765,000 |
| 10087166 |
Cyclic amine azaheterocyclic carboxamides |
Bayard R. Huck, Constantin Neagu, Reinaldo Jones, Yufang Xiao, Igor Mochalkin |
2018-10-02 |
$122,453,000 |
| 10080750 |
Aminopyrimidine derivatives for use as modulators of kinase activity |
Ruoxi Lan, Bayard R. Huck, Lizbeth Celeste Deselm, Hui Qiu, Yufang Xiao +3 more |
2018-09-25 |
$93,342,000 |
| 10080753 |
Heterocyclic carboxamides as modulators of kinase activity |
Bayard R. Huck, Yufang Xiao, Ruoxi Lan, Lizbeth Celeste De Selm, Constantin Neagu +3 more |
2018-09-25 |
$93,342,000 |
| 9981925 |
Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors |
Bayard R. Huck, Ruoxi Lan, Justin Potnick, Lizbeth Celeste Deselm, Mark Cronin +4 more |
2018-05-29 |
$71,857,000 |
| 9867826 |
Heterocycles as modulators of kinase activity |
Ruoxi Lan, Yufang Xiao, Bayard R. Huck, Andreas Goutopoulos |
2018-01-16 |
$61,578,000 |
| 9850255 |
Heterocyclic derivatives as modulators of kinase activity |
Ruoxi Lan, Bayard R. Huck, Yufang Xiao |
2017-12-26 |
$116,491,000 |
| 9815836 |
Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof |
Henry Yu, Ruoxi Lan, Catherine Jorand-Lebrun, Theresa L. Johnson, Andreas Goutopoulos |
2017-11-14 |
$82,691,000 |
| 9708324 |
Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof |
Henry Yu, Ruoxi Lan, Catherine Jorand-Lebrun, Theresa L. Johnson, Andreas Goutopoulos |
2017-07-18 |
$61,300,000 |
| 9662330 |
Aminopyrimidine derivatives for use as modulators of kinase activity |
Ruoxi Lan, Bayard R. Huck, Lizbeth Celeste Deselm, Hui Qiu, Yufang Xiao +3 more |
2017-05-30 |
$63,958,000 |
| 9624246 |
Pyridazinone macrocycles as IRAK inhibitors and uses thereof |
Ruoxi Lan, Catherine Jorand-Lebrun, Henry Yu, Andreas Goutopoulos |
2017-04-18 |
$55,580,000 |
| 9586938 |
Cyclic amine azaheterocyclic carboxamides |
Bayard R. Huck, Constantin Neagu, Reinaldo Jones, Yufang Xiao, Igor Mochalkin |
2017-03-07 |
$72,118,000 |
| 9580443 |
Heterocyclic derivatives as modulators of kinase activity |
Ruoxi Lan, Bayard R. Huck, Yufang Xiao |
2017-02-28 |
$88,591,000 |
| 9458134 |
Heterocycles as modulators of kinase activity |
Ruoxi Lan, Yufang Xiao, Bayard R. Huck, Andreas Goutopoulos |
2016-10-04 |
$87,067,000 |
| 9440968 |
Substituted pyrido[3,2-d]pyrimidines for treating cancer |
Bayard R. Huck, Ruoxi Lan, Justin Potnick, Lizbeth Celeste Deselm, Mark Cronin +4 more |
2016-09-13 |
$142,282,000 |
| 9434714 |
Pyrimidine imidazole amines as modulators of kinase activity |
Ruoxi Lan, Yufang Xiao, Bayard R. Huck, Andreas Goutopoulos |
2016-09-06 |
$101,652,000 |
| 9321760 |
Aminopyrimidine derivatives for use as modulators of kinase activity |
Ruoxi Lan, Bayard R. Huck, Lizbeth Celeste Deselm, Hui Qiu, Yufang Xiao +3 more |
2016-04-26 |
$191,129,000 |
